AEON Biopharma | SCHEDULE 13G: Others
AEON Biopharma | 8-K: Current report
AEON Biopharma | SCHEDULE 13G/A: Others
AEON Biopharma | SCHEDULE 13G/A: Others
AEON Biopharma | 8-K: Current report
AEON Biopharma | DEF 14A: Definitive information statements
AEON Biopharma | SCHEDULE 13D: Others
AEON Biopharma | SCHEDULE 13G: Others
AEON Biopharma | SCHEDULE 13G: Others
AEON Biopharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
AEON Biopharma | SCHEDULE 13G: Others
AEON Biopharma | 8-K: Current report
AEON Biopharma | 424B5: Prospectus
AEON Biopharma | 8-K: Current report
AEON Biopharma | 424B5: Prospectus
AEON Biopharma | 8-K: Current report
AEON Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Blue Owl Capital Holdings LP(8.45%)
AEON Biopharma | 424B3: Prospectus
AEON Biopharma | 8-K: AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
AEON Biopharma | 10-Q: Q3 2024 Earnings Report